XP Inc. logo XP - XP Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $37.00 DETAILS
HIGH: $37.00
LOW: $37.00
MEDIAN: $37.00
CONSENSUS: $37.00
UPSIDE: 21.67%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Moderate
Trading 18.4% below fair value
Current Price $30.41
Bear Case $26.08 14.2% downside ($26.08 - $30.41) / $30.41 = -14.2% ROTCE 18.3% → 2.39x TBV
Fair Value $37.26 22.5% upside ($37.26 - $30.41) / $30.41 = 22.5% ROTCE 24.4% → 3.41x TBV
Bull Case $48.44 59.3% upside ($48.44 - $30.41) / $30.41 = 59.3% ROTCE 28.0% → 4.00x TBV

Adjust Assumptions

24.4%
10.0%

Key Value Driver

ROTCE (24.4%) vs. cost of equity (10.0%)

Implied Market Multiple 3.79x

Plain-Language Summary

With ROTCE of 24.4% vs. 10.0% cost of equity, fair P/TBV is 3.41x on $8.03 tangible book, implying $37.26 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (10 analysts) $37.00
Analyst Range $37.00 – $37.00
Divergence from AlphaVal 1%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
ℹ Financial statements were converted from BRL into USD using USDBRL at 0.2001 USD per BRL.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly